{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:42:14Z","timestamp":1787312534781,"version":"build-2736575974"},"reference-count":80,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2766,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2008.01696.x","type":"journal-article","created":{"date-parts":[[2008,2,4]],"date-time":"2008-02-04T07:11:40Z","timestamp":1202109100000},"page":"791-798","source":"Crossref","is-referenced-by-count":85,"title":["The triad of erectile dysfunction, hypogonadism and the metabolic syndrome"],"prefix":"10.1155","volume":"62","author":[{"given":"R.","family":"Shabsigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. S.","family":"Channer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Eardley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gooren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Heufelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Meryn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zitzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,2,4]]},"reference":[{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2003-0005","article-title":"Androgens and cardiovascular disease","volume":"24","author":"Liu","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1210\/er.2001-0025","article-title":"Androgens and coronary artery disease","volume":"24","author":"Wu","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00129784-200505030-00001","article-title":"Testosterone and atherosclerosis in aging men: purported association and clinical implications","volume":"5","author":"Jones","year":"2005","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/jcem.87.8.8762","article-title":"Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study","volume":"87","author":"Hak","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.ijir.3901499","article-title":"Epidemiology: testosterone and the metabolic syndrome","volume":"19","author":"Svartberg","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1210\/jcem.82.11.4387","article-title":"Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis","volume":"82","author":"Hajjar","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"67M","DOI":"10.1016\/j.amjcard.2005.10.009","article-title":"Cardiovascular issues in hypogonadism and testosterone therapy","volume":"96","author":"Shabsigh","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/01.CIR.102.16.1906","article-title":"Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study","volume":"102","author":"English","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehi443","article-title":"Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial","volume":"27","author":"Malkin","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0889-8529(03)00074-4","article-title":"Epidemiologic trends in overweight and obesity","volume":"32","author":"Ogden","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2008.01696.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1017\/S0007114500000957","article-title":"The metabolic syndrome - a neuroendocrine disorder?","volume":"83","author":"Bjorntorp","year":"2000","journal-title":"Br J Nutr"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB12|cit12","first-page":"e13","article-title":"Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"24","author":"Grundy","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2004-0432","article-title":"Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk","volume":"89","author":"Carr","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2337\/diacare.28.11.2745","article-title":"Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diabres.2004.11.001","article-title":"Predictive values of anthropometric measurements for multiple metabolic disorders in Asian populations","volume":"69","author":"Shiwaku","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archinte.164.10.1066","article-title":"Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women","volume":"164","author":"Hu","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1210\/jc.2004-0762","article-title":"Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men","volume":"90","author":"Kalme","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1210\/jc.2005-1326","article-title":"Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men","volume":"91","author":"Kupelian","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","article-title":"Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men","volume":"27","author":"Laaksonen","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2337\/diacare.25.1.55","article-title":"Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study","volume":"25","author":"Oh","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/diacare.23.4.490","article-title":"Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study","volume":"23","author":"Stellato","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2337\/dc06-1579","article-title":"Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"30","author":"Selvin","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2004-1158","article-title":"Endogenous sex hormones and metabolic syndrome in aging men","volume":"90","author":"Muller","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2337\/diab.45.11.1605","article-title":"The pituitary-gonadal axis and health in elderly men: a study of men born in 1913","volume":"45","author":"Tibblin","year":"1996","journal-title":"Diabetes"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.2005.02299.x","article-title":"Androgens, insulin resistance and vascular disease in men","volume":"63","author":"Kapoor","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/01.ju.0000169490.78443.59","article-title":"Hypogonadism and metabolic syndrome: implications for testosterone therapy","volume":"174","author":"Makhsida","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1385\/ENDO:27:1:011","article-title":"Evaluation of insulin sensitivity in patients with Klinefelter\u2019s syndrome: a hyperinsulinemic euglycemic clamp study","volume":"27","author":"Yesilova","year":"2005","journal-title":"Endocrine"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2337\/diacare.28.7.1636","article-title":"Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men","volume":"28","author":"Pitteloud","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB31|cit31","first-page":"3673","article-title":"Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels","volume":"84","author":"Isidori","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1210\/endo.140.11.7088","article-title":"Expression of functional leptin receptors in rodent Leydig cells","volume":"140","author":"Caprio","year":"1999","journal-title":"Endocrinology"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.ijo.0801467","article-title":"A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adiposity","volume":"25","author":"Soderberg","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2265.1999.00741.x","article-title":"Serum leptin levels in healthy ageing men: are decreased serum testosterone and increased adiposity in elderly men the consequence of leptin deficiency?","volume":"51","author":"Van Den Saffele","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1210\/jc.2004-2190","article-title":"Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men","volume":"90","author":"Pitteloud","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.ijo.0801406","article-title":"Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat","volume":"24","author":"Lima","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB37|cit37","first-page":"1140","article-title":"Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men","volume":"76","author":"Vermeulen","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/er.2004-0017","article-title":"Gonadotropin-releasing hormone agonists in the treatment of prostate cancer","volume":"26","author":"Labrie","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.metabol.2004.07.010","article-title":"Marked hyperglycemia after androgen-deprivation therapy for prostate cancer and usefulness of pioglitazone for its treatment","volume":"54","author":"Inaba","year":"2005","journal-title":"Metabolism"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.2002.01551.x","article-title":"Long-term effects of androgen deprivation therapy in prostate cancer patients","volume":"56","author":"Basaria","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cncr.21642","article-title":"Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy","volume":"106","author":"Basaria","year":"2006","journal-title":"Cancer"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.ijir.3901471","article-title":"Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy","volume":"18","author":"Braga-Basaria","year":"2006","journal-title":"Int J Impot Res"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"27","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3816\/CGC.2003.n.008","article-title":"Changes in body composition during hormonal therapy for prostate cancer","volume":"2","author":"Smith","year":"2003","journal-title":"Clin Prostate Cancer"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.urology.2003.10.063","article-title":"Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer","volume":"63","author":"Smith","year":"2004","journal-title":"Urology"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2005-2507","article-title":"Insulin sensitivity during combined androgen blockade for prostate cancer","volume":"91","author":"Smith","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.juro.2006.03.057","article-title":"The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters","volume":"176","author":"Yannucci","year":"2006","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/jcem.87.1.8172","article-title":"The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men","volume":"87","author":"Singh","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2004-1649","article-title":"Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors","volume":"147","author":"Singh","year":"2006","journal-title":"Endocrinology"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/01.ju.0000127740.96006.1a","article-title":"Changing patterns in competing causes of death in men with prostate cancer: a population based study","volume":"1","author":"Lu-Yao","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.urolonc.2005.03.018","article-title":"Promoting general health during androgen deprivation therapy (ADT): a rapid 10-step review for your patients","volume":"23","author":"Moyad","year":"2005","journal-title":"Urol Oncol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc06-1426","article-title":"Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity","volume":"30","author":"Kapoor","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.2337\/dc06-0197","article-title":"Contrasting testosterone concentrations in type 1 and type 2 diabetes","volume":"29","author":"Tomar","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/eje.1.02166","article-title":"Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes","volume":"154","author":"Kapoor","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/tam.6.1.1.7","article-title":"Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency","volume":"6","author":"Boyanov","year":"2003","journal-title":"Aging Male"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/j.1550-8528.1993.tb00618.x","article-title":"Androgen treatment of abdominally obese men","volume":"1","author":"Marin","year":"1993","journal-title":"Obes Res"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01542116","article-title":"Changes in erectile responsiveness during androgen replacement therapy","volume":"12","author":"Bancroft","year":"1983","journal-title":"Arch Sex Behav"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0022-5347(01)66141-X","article-title":"Improvement of sexual function in testosterone deficient men treated for 1\u2003year with a permeation enhanced testosterone transdermal system","volume":"155","author":"Arver","year":"1996","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-2265.2003.01764.x","article-title":"Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction","volume":"58","author":"Aversa","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.eururo.2006.06.049","article-title":"Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences","volume":"50","author":"Greco","year":"2006","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/01.ju.0000165389.73148.d1","article-title":"Health issues of men: prevalence and correlates of erectile dysfunction","volume":"174","author":"Shabsigh","year":"2005","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01275152","article-title":"The effects of testosterone on the cavernous tissue and erectile function","volume":"15","author":"Shabsigh","year":"1997","journal-title":"World J Urol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1745-7262.2006.00105.x","article-title":"Recent insights into androgen action on the anatomical and physiological substrate of penile erection","volume":"8","author":"Gooren","year":"2006","journal-title":"Asian J Androl"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.eururo.2004.10.021","article-title":"Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum","volume":"47","author":"Zhang","year":"2005","journal-title":"Eur Urol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1210\/en.2003-1699","article-title":"Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa","volume":"145","author":"Morelli","year":"2004","journal-title":"Endocrinology"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1439-0272.2006.00705.x","article-title":"Dramatic improvement of penile venous leakage upon testosterone administration. A case report and review of literature","volume":"38","author":"Yassin","year":"2006","journal-title":"Andrologia"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0094-0143(21)00691-1","article-title":"Sexuality and aging","volume":"22","author":"Schiavi","year":"1995","journal-title":"Urol Clin North Am"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1210\/jc.2005-0247","article-title":"Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men","volume":"90","author":"Gray","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/archinte.166.15.1660","article-title":"Low serum testosterone and mortality in male veterans","volume":"166","author":"Shores","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archinte.167.12.1252","article-title":"Sex steroids and all-cause mortality and cause-specific mortality in men","volume":"167","author":"Araujo","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(05)66911-5","article-title":"Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men","volume":"366","author":"Holden","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1743-6109.2005.20120.x","article-title":"Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction","volume":"2","author":"Bansal","year":"2005","journal-title":"J Sex Med"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0022-5347(06)00503-9","article-title":"Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study","volume":"176","author":"Kupelian","year":"2006","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.juro.2006.08.108","article-title":"The natural progression and remission of erectile dysfunction: results from the Massachusetts Male Aging Study","volume":"177","author":"Travison","year":"2007","journal-title":"J Urol"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.291.24.2978","article-title":"Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial","volume":"291","author":"Esposito","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.292.12.1440","article-title":"Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial","volume":"292","author":"Esposito","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1742-1241.2006.01101.x","article-title":"The evolving role of testosterone in the treatment of erectile dysfunction","volume":"60","author":"Shabsigh","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2008.01696.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1743-6109.2006.00245.x","article-title":"Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence","volume":"3","author":"Traish","year":"2006","journal-title":"J Sex Med"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2008.01696.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2008.01696.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T01:05:40Z","timestamp":1643331940000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2008.01696.x"}},"subtitle":["ED, hypogonadism and the metabolic syndrome"],"short-title":[],"issued":{"date-parts":[[2008,2,4]]},"references-count":80,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01696.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2,4]]}}}